KRAS and pancreatic ductal adenocarcinoma: So, we used its AF (variant coverage over total coverage) to assess the purity of the tumors (AF fold 2 alleles fold 100), a method often used in pancreatic ductal adenocarcinoma with KRAS (Biankin et al, 2012).